Puma Biotechnology, Pierre Fabre enter into license agreement to develop and commercialize NERLYNX in Europe

Image: Puma Biotechnology, Pierre Fabre enter into license agreement to develop and commercialize NERLYNX in Europe. Photo: courtesy of Darko Stojanovic/Pixabay.